General Information of the Compound
Compound ID
CP0064613
Compound Name
(2S)-2-ethoxy-3-(4-{2-[4-(methanesulfonyloxy)phenyl]ethoxy}phenyl)propanoic acid
    Show/Hide
Synonyms
(2S)-2-ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
(S)-2-Ethoxy-3-(4-(4-((methylsulfonyl)oxy)phenethoxy)phenyl)propanoic acid
(S)-2-Ethoxy-3-[4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
(S)-2-Ethoxy-3-{4-[2-(4-methanesulfonyloxy-phenyl)-ethoxy]-phenyl}-propionic acid
(S)-2-Ethoxy-3-{4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl}propionic acid
251565-85-2
6734037O3L
AR-H039242XX
AZ 242
AZ-242
BR-44608
Galida
TESAGLITAZAR
Tesaglitazar
UNII-6734037O3L
    Show/Hide
Structure
Formula
C20H24O7S
Molecular Weight
408.472
Canonical SMILES
CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(O)=O
    Show/Hide
InChI
InChI=1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m0/s1
    Show/Hide
InChIKey
CXGTZJYQWSUFET-IBGZPJMESA-N
CAS
251565-85-2
Physicochemical Property
logP
2.6787
Rotatable Bonds
11
Heavy Atom Count
28
Polar Areas
99.13
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 208901
SID: 14830941
ChEMBL ID
CHEMBL282686
DrugBank ID
DB06536
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00910, Peroxisome proliferator-activated receptor alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  2
1
EC50 = 820 nM
   TI
   LI
   LO
   TS
2
EC50 = 9798 nM
   TI
   LI
   LO
   TS
CL000044 CV-1 Chlorocebus aethiops (Green monkey)  1
1
EC50 = 3124 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 3800 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 1700 nM
2 IC50 = 3800 nM
3 Ki = 1000 nM
Protein ID: PT01919, Peroxisome proliferator-activated receptor alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000043 U2OS Homo sapiens (Human)  1
1
EC50 = 1700 nM
   TI
   LI
   LO
   TS
Protein ID: PT00915, Peroxisome proliferator-activated receptor gamma
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  2
1
EC50 = 13 nM
   TI
   LI
   LO
   TS
2
EC50 = 3528 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 360 nM
   TI
   LI
   LO
   TS
CL000044 CV-1 Chlorocebus aethiops (Green monkey)  1
1
EC50 = 704 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 350 nM
2 Ki = 18 nM
Protein ID: PT02973, Peroxisome proliferator-activated receptor gamma
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000043 U2OS Homo sapiens (Human)  1
1
EC50 = 250 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 250 nM
2 Ki = 200 nM
Clinical Information about the Compound
Drug 1 ( TESAGLITAZAR )
Drug Name TESAGLITAZAR
Indication
Type-1 diabetes
Phase 3
Target(s)
Peroxisome proliferator-activated receptor gamma (PPAR-gamma)
Modulator
Peroxisome proliferator-activated receptor alpha (PPARA)
Modulator